[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Mr. Mir A. Imran", "age": 68, "title": "Executive Chairman", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 40000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Talat  Imran", "age": 43, "title": "CEO & Director", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 105818, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 416000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alireza  Javadi", "title": "Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betsy  Gutierrez", "title": "Senior Vice President of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.5047, "open": 0.5047, "dayLow": 0.49, "dayHigh": 0.5099, "regularMarketPreviousClose": 0.5047, "regularMarketOpen": 0.5047, "regularMarketDayLow": 0.49, "regularMarketDayHigh": 0.5099, "payoutRatio": 0.0, "beta": -0.016, "forwardPE": -0.49465346, "volume": 202349, "regularMarketVolume": 202349, "averageVolume": 1860398, "averageVolume10days": 372950, "averageDailyVolume10Day": 372950, "bid": 0.4848, "ask": 0.5094, "bidSize": 3, "askSize": 3, "marketCap": 36467204, "fiftyTwoWeekLow": 0.387, "fiftyTwoWeekHigh": 3.75, "priceToSalesTrailing12Months": 30.389338, "fiftyDayAverage": 0.5288, "twoHundredDayAverage": 1.056655, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 31752954, "profitMargins": 0.0, "floatShares": 33616892, "sharesOutstanding": 47898200, "sharesShort": 103465, "sharesShortPriorMonth": 980011, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0022, "heldPercentInsiders": 0.19562, "heldPercentInstitutions": 0.1701, "shortRatio": 0.15, "shortPercentOfFloat": 0.0027, "impliedSharesOutstanding": 72992800, "bookValue": -0.142, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -29686000, "trailingEps": -0.9, "forwardEps": -1.01, "enterpriseToRevenue": 26.461, "enterpriseToEbitda": -0.713, "52WeekChange": -0.78070176, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 0.4996, "targetHighPrice": 9.0, "targetLowPrice": 5.0, "targetMeanPrice": 7.75, "targetMedianPrice": 8.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 10216000, "totalCashPerShare": 0.213, "ebitda": -44545000, "totalDebt": 21617000, "quickRatio": 0.495, "currentRatio": 0.537, "totalRevenue": 1200000, "revenuePerShare": 0.036, "returnOnAssets": -0.93942, "grossProfits": 1200000, "freeCashflow": -13116250, "operatingCashflow": -31010000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -37.9675, "financialCurrency": "USD", "symbol": "RANI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Rani Therapeutics Holdings, Inc", "postMarketTime": 1757720225, "regularMarketTime": 1757707200, "exchange": "NGM", "messageBoardId": "finmb_242425883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": 1.1209, "postMarketPrice": 0.5052, "postMarketChange": 0.00560004, "regularMarketChange": -0.00510001, "regularMarketDayRange": "0.49 - 0.5099", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1860398, "fiftyTwoWeekLowChange": 0.1126, "fiftyTwoWeekLowChangePercent": 0.29095608, "fiftyTwoWeekRange": "0.387 - 3.75", "fiftyTwoWeekHighChange": -3.2504, "fiftyTwoWeekHighChangePercent": -0.86677337, "fiftyTwoWeekChangePercent": -78.070175, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "earningsCallTimestampStart": 1743453000, "earningsCallTimestampEnd": 1743453000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.9, "epsForward": -1.01, "epsCurrentYear": -0.54, "priceEpsCurrentYear": -0.92518514, "fiftyDayAverageChange": -0.029200017, "fiftyDayAverageChangePercent": -0.055219397, "twoHundredDayAverageChange": -0.55705506, "twoHundredDayAverageChangePercent": -0.5271872, "priceToBook": -3.5183096, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "cryptoTradeable": false, "regularMarketChangePercent": -1.0105, "regularMarketPrice": 0.4996, "longName": "Rani Therapeutics Holdings, Inc.", "corporateActions": [], "marketState": "CLOSED", "displayName": "Rani Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]